Prairie Education & Research Coope… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1984

Legal Domicile

Phone

2174929100

Tax Period

2024-07-01 to 2025-06-30

Prairie Education & Research Cooperative, founded in 1984, is a community nonprofit in the Medical Research sector that reported $3.0M in total revenue in fiscal year 2024. Revenue fell 24% from the prior year — a significant decline worth monitoring. Expenses of $3.5M exceeded revenue, resulting in a 14% operating deficit.

Mission

THE PURPOSE OF THE ORGANIZATION IS TO ENGAGE IN ACTIVE CONTINUOUS MEDICAL RESEARCH TO FURTHER THE UNDERSTANDING OF APPLICATIONS OF NEW MODES OF THERAPY FOR CARDIOVASCULAR DISEASE, DIABETES AND NEUROLOGICAL DISORDERS.

Program Service Accomplishments

Program 1

Expenses: $1,544,192 Revenue: $1,672,650

Continuing Education: Provide all forms of continuing education for the entire Hospital Sisters Health System. The program strives to provide educational activities that are based on identified gaps through a formal needs assessment involving the educational facilitators, program planners, and content reviewers. The scope of the programs include, but are not limited to: cardiac, vascular, and general medical care, including prevention, diagnosis, treatment, rehabilitation, quality improvement, and cost effectiveness. There were approximately 90 CME and 38 CNE events conducted in FY 2025.

Program 2

Expenses: $1,440,515 Revenue: $1,285,694

Participate in Phase I-IV clinical trials as an enrolling site in a wide range of therapeutic areas with a focus on cardiovascular, diabetes, and neurology research. Trials are sponsored and funded by device and pharmaceutical companies. Participated in approximately 38 cardiovascular trials, 11 diabetes trials, and 15 neurology trials in FY 2025. Conduct Clinical Events Committee (CEC) and Data and Safety Monitoring Board (DSMB) management for medical device sponsors. Provide individuals with expertise to advise the sponsor on the continuing safety of trial subjects. Provide oversight of trial data to determine that sponsors are compliant with conducting trials that are ethical, safe for subjects, and produce good, reliable data. Provided CEC/DSMB management for approximately 3 clinical trials in FY 2025.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $32,071

Program Service Revenue $2,958,344

Investment Income $54,122

Other Revenue $0

TOTAL REVENUE $3,044,537

Expense Breakdown

Grants Paid $0

Salaries & Benefits $2,919,938

Fundraising Expenses $0

Program Expenses $2,984,707

Other Expenses $549,067

TOTAL EXPENSES $3,469,005

Year-over-Year Comparison

	2024	2023	Change
Revenue	$3,044,537	$4,015,074	-0.2%
Expenses	$3,469,005	$3,905,132	-0.1%
Net Income	$-424,468	$109,942	-4.9%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$1,495,531

Total Directors

$4,185,064

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Brenda Jeffers	Chair	2.5	Officer Director	$0	$0	$0
JENNY CHAMBERS	Executive Director - PERC	40.0	Officer Director	$195,435	$18,445	$213,880
LARRY HARDY	Board Member, Chair (began 11/1/24)	2.5	Officer Director	$0	$0	$0
AVINASH MURTHY MD	Board Member / Physician	1.0	Director	$0	$29,292	$1,029,753
Bharath Rajagopalan MD	Board Member / Physician	60.0	Director	$1,340,660	$58,473	$1,399,133
Dennis Rizzo	Board Member	1.0	Director	$0	$0	$0
JANET ROGLIS	Board Member	1.0	Director	$0	$0	$0
Kevin Lewis MD	BOARD MEMBER / HSHS Chief Clinical Officer	2.5	Director	$0	$137,374	$884,394
PETER KUNG	Board Member/HSHS SVP-CHIEF STRATEGY OFFICER	1.2	Director	$0	$112,570	$657,904
Michael Scialdone	Treasurer / HSHS SVP & CFO	0.3	Officer	$0	$132,635	$912,947
Paige Toth	Secretary	0.3	Officer	$0	$75,167	$368,704
Lauren McNeil	Manager - Research	60.0	Highest	$101,703	$19,325	$121,028

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$3,044,537	$3,469,005	$4,614,214	$-424,468
2024	No data	No data	No data	No data
2023	$4,083,136	$3,955,138	$4,983,358	$127,998
2022	$4,199,666	$3,917,434	$4,417,610	$282,232
2021	$3,470,955	$3,494,722	$4,345,359	$-23,767
2020	$3,027,765	$3,215,311	$4,237,025	$-187,546
2019	$2,658,216	$2,923,098	$4,372,017	$-264,882
2018	$3,484,945	$3,191,692	$4,689,793	$293,253

Prairie Education & Research Cooperative